General Information of Drug (ID: DMM2JXP)

Drug Name
VX-787 Drug Info
Synonyms Pimodivir
Indication
Disease Entry ICD 11 Status REF
Influenza A virus infection 1E30 Phase 3 [1]
Cross-matching ID
PubChem CID
67286591
CAS Number
CAS 1629869-44-8
TTD Drug ID
DMM2JXP

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Influenza Polymerase basic protein 2 (Influ PB2) TT62KQV PB2_I34A1 Inhibitor [2]

References

1 ClinicalTrials.gov (NCT03376321) A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection. U.S. National Institutes of Health.
2 Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2. J Med Chem. 2014 Aug 14;57(15):6668-78.